Total Payments
$3,410
2024 Payments
$298.68
Companies
20
Transactions
192
Medicare Patients
12,668
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$3,225 (94.6%)
Education$184.98 (5.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,225 | 190 | 94.6% |
| Education | $184.98 | 2 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $786.82 | 63 | $0 (2024) |
| Amgen Inc. | $763.60 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $367.44 | 28 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $234.90 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $211.88 | 11 | $0 (2020) |
| Novo Nordisk Inc | $193.67 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $184.98 | 2 | $0 (2017) |
| Abbott Laboratories | $116.38 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $110.62 | 7 | $0 (2023) |
| Tactile Systems Technology Inc | $85.06 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $298.68 | 15 | Novartis Pharmaceuticals Corporation ($86.24) |
| 2023 | $436.42 | 11 | Novo Nordisk Inc ($124.99) |
| 2022 | $27.72 | 2 | Amgen Inc. ($14.84) |
| 2021 | $19.75 | 1 | Novo Nordisk Inc ($19.75) |
| 2020 | $70.29 | 4 | Amgen Inc. ($36.26) |
| 2019 | $875.26 | 59 | Amgen Inc. ($295.67) |
| 2018 | $862.96 | 60 | Novartis Pharmaceuticals Corporation ($244.58) |
| 2017 | $818.78 | 40 | Novartis Pharmaceuticals Corporation ($263.11) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Cardiology | ||||||
| 07/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Cardiology | ||||||
| 06/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.52 | General |
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/27/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 03/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/08/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: Not Applicable | ||||||
| 02/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.96 | General |
| 01/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/13/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/05/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $116.38 | General |
| Category: Heart Failure | ||||||
| 10/03/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/01/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/05/2023 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 04/06/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.18 | General |
| Category: Cardiovascular | ||||||
| 03/20/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/27/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/23/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Obesity | ||||||
| 02/23/2023 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $55.52 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,327 | 3,738 | $777,096 | $205,782 |
| 2022 | 26 | 3,519 | 5,266 | $1.4M | $273,721 |
| 2021 | 27 | 3,578 | 5,408 | $1.1M | $293,528 |
| 2020 | 30 | 3,244 | 4,622 | $913,289 | $237,933 |
Total Patients
12,668
Total Services
19,034
Medicare Billing
$1.0M
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 632 | 1,144 | $318,032 | $113,018 | 35.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 206 | 486 | $96,594 | $32,883 | 34.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 73 | 73 | $40,369 | $10,794 | 26.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 86 | 87 | $37,668 | $9,814 | 26.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 552 | 763 | $45,017 | $8,821 | 19.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $27,577 | $8,532 | 30.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 66 | 67 | $13,467 | $4,688 | 34.8% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 152 | 340 | $15,300 | $3,041 | 19.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 47 | 47 | $88,947 | $2,915 | 3.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 12 | $4,920 | $1,873 | 38.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 34 | 34 | $29,852 | $1,713 | 5.7% |
| 85610 | Blood test, clotting time | Office | 2023 | 155 | 362 | $5,792 | $1,520 | 26.3% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 13 | 13 | $4,394 | $1,364 | 31.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 22 | 22 | $19,316 | $1,102 | 5.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 66 | 66 | $5,610 | $1,072 | 19.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 11 | 11 | $11,242 | $991.10 | 8.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 66 | 66 | $3,762 | $717.32 | 19.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 14 | 14 | $5,166 | $295.54 | 5.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 35 | $420.00 | $294.00 | 70.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 15 | 15 | $1,779 | $179.69 | 10.1% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Facility | 2023 | 16 | 18 | $1,872 | $157.64 | 8.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 619 | 1,217 | $325,911 | $121,665 | 37.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 302 | 706 | $135,306 | $43,623 | 32.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 105 | 108 | $57,748 | $18,190 | 31.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 261 | 262 | $220,796 | $14,010 | 6.3% |
About Dr. Mark Harrison, MD
Dr. Mark Harrison, MD is a Nuclear Cardiology healthcare provider based in Poughkeepsie, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285799585.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Harrison, MD has received a total of $3,410 in payments from pharmaceutical and medical device companies, with $298.68 received in 2024. These payments were reported across 192 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,225).
As a Medicare-enrolled provider, Harrison has provided services to 12,668 Medicare beneficiaries, totaling 19,034 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Cardiology
- Other Specialties Cardiovascular Disease
- Location Poughkeepsie, NY
- Active Since 12/27/2006
- Last Updated 09/07/2018
- Taxonomy Code 207UN0901X
- Entity Type Individual
- NPI Number 1285799585
Products in Payments
- ENTRESTO (Drug) $622.85
- Corlanor (Drug) $584.24
- BRILINTA (Drug) $268.00
- XARELTO (Drug) $234.90
- PRADAXA (Drug) $211.88
- Repatha (Biological) $179.36
- LEQVIO (Drug) $163.97
- Wegovy (Drug) $144.74
- ELIQUIS (Drug) $124.51
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $116.38
- Flexitouch Plus (Device) $85.06
- LOKELMA (Drug) $83.38
- WATCHMAN FLX (Device) $47.01
- PRALUENT ALIROCUMAB INJECTION (Biological) $42.59
- Arcalyst (Drug) $32.32
- LifeVest (Device) $24.62
- BODYGUARDIAN REMOTE MONITORING SYSTEM (Device) $23.40
- OPSUMIT (Drug) $18.73
- PRALUENT (Biological) $16.69
- OPSUMIT MACITENTAN (Drug) $16.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nuclear Cardiology Doctors in Poughkeepsie
Dr. Anthony Messina, M.d, M.D
Nuclear Cardiology — Payments: $15,351
Nuclear Cardiology $15,351
Dr. Ronald Cuffe, Md, MD
Nuclear Cardiology — Payments: $3,937
Nuclear Cardiology $3,937
Dr. William Lee, Md Phd Facc, MD PHD FACC
Nuclear Cardiology — Payments: $1,757
Nuclear Cardiology $1,757
Dr. Julie Ling, Md Facc, MD FACC
Nuclear Cardiology — Payments: $1,591
Nuclear Cardiology $1,591